Abstract
[Display omitted]
The in vitro anticancer potential of morpholine hydrazones scaffold (1-17) was tested against human cancer cell lines like HepG2 and MCF-7. Analogs 13 had similar substantial cytotoxic effects towards HepG2 with IC50 value 6.31±1.03μmol/L when compared with the standard Doxorubicin (IC50 value 6.00±0.80μmol/L).
In this paper, synthesis and anticancer activities of morpholine hydrazones scaffold (1-17) thoroughly studied. Small series of morpholine hydrazones synthesized by treating 5-morpholinothiophene-2-carbaldehyde with different aryl hydrazides to form morpholine hydrazones scaffold (1-17). The in vitro anticancer potential of all these compounds was checked against human cancer cell lines like HepG2 (human hepatocellular liver carcinoma) and MCF-7 (human breast adenocarcinoma). Analogs 13 had similar substantial cytotoxic effects towards HepG2 with IC50 value 6.31±1.03μmol/L when compared with the standard Doxorubicin (IC50 value 6.00±0.80μmol/L); while compounds 5, 8 and 9 showed potent cytotoxicity against MCF-7 with IC50 value 7.08±0.42μmol/L, 1.26±0.34μmol/L and 11.22±0.22μmol/L respectively when compared with the standard Tamoxifen (IC50=11.00±0.40μmol/L). Molecular docking studies also performed to understand the binding interaction.